Código QR (código de barras bidimensional)

Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

The Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS) project designed to facilitate the development of new drugs for the treatment of cognitive impairments in people with schizophrenia, identified three drug mechanisms of particular interest: dopaminergic, cholinerg...

ver descrição completa

Na minha lista:
Autor principal: Maju Mathew Koola
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016-06-01
coleção:Schizophrenia Research: Cognition
Assuntos:
Schizophrenia
Cognitive impairments
Kynurenine pathway
Pharmacogenetics
α-7 nicotinic receptor and NMDA receptor
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S221500131630004X
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados